Salt-Sensitivity of Blood Pressure and Insulin Resistance.

PPARγ blood pressure immune activation insulin resistance salt-sensitivity

Journal

Frontiers in physiology
ISSN: 1664-042X
Titre abrégé: Front Physiol
Pays: Switzerland
ID NLM: 101549006

Informations de publication

Date de publication:
2021
Historique:
received: 12 10 2021
accepted: 18 11 2021
entrez: 30 12 2021
pubmed: 31 12 2021
medline: 31 12 2021
Statut: epublish

Résumé

Salt sensitivity of blood pressure (SSBP) is an independent risk factor for cardiovascular morbidity and mortality that is seen in both hypertensive and normotensive populations. Insulin resistance (IR) strongly correlates with SSBP and affects nearly 50% of salt sensitive people. While the precise mechanism by which IR and SSBP relate remains elusive, several common pathways are involved in the genesis of both processes, including vascular dysfunction and immune activation. Vascular dysfunction associated with insulin resistance is characterized by loss of nitric oxide (NO)-mediated vasodilation and heightened endothelin-1 induced vasoconstriction, as well as capillary rarefaction. It manifests with increased blood pressure (BP) in salt sensitive murine models. Another common denominator in the pathogenesis of insulin resistance, hypertension, and salt sensitivity (SS) is immune activation involving pro-inflammatory cytokines like tumor necrosis factor (TNF)-α, IL-1β, and IL-6. In the last decade, a new understanding of interstitial sodium storage in tissues such as skin and muscle has revolutionized traditional concepts of body sodium handling and pathogenesis of SS. We have shown that interstitial Na

Identifiants

pubmed: 34966295
doi: 10.3389/fphys.2021.793924
pmc: PMC8711096
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

793924

Informations de copyright

Copyright © 2021 Ertuglu, Elijovich, Laffer and Kirabo.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Hypertension. 2000 Apr;35(4):864-8
pubmed: 10775552
Clin Exp Pharmacol Physiol. 1996 Apr;23(4):287-90
pubmed: 8717063
Proc Natl Acad Sci U S A. 1996 Dec 10;93(25):14564-8
pubmed: 8962092
Hypertension. 2010 Feb;55(2):500-7
pubmed: 20038749
Microcirculation. 2007 Jun-Jul;14(4-5):289-98
pubmed: 17613802
J Clin Invest. 1996 Jun 1;97(11):2601-10
pubmed: 8647954
Can J Physiol Pharmacol. 2020 Sep;98(9):604-610
pubmed: 32083942
Hypertension. 2010 Mar;55(3):755-61
pubmed: 20142563
J Immunol. 2016 Mar 15;196(6):2476-2491
pubmed: 26889045
J Hypertens. 1997 Dec;15(12 Pt 1):1485-91
pubmed: 9431856
J Clin Endocrinol Metab. 2003 Jun;88(6):2399-403
pubmed: 12788834
Diabetes. 2010 Nov;59(11):2898-903
pubmed: 20724582
Am J Hypertens. 1998 Apr;11(4 Pt 1):397-402
pubmed: 9607376
Cell Death Dis. 2017 Oct 5;8(10):e3074
pubmed: 28981106
Am J Physiol Heart Circ Physiol. 2009 Nov;297(5):H1647-54
pubmed: 19666848
Circulation. 2013 Oct 22;128(17):1910-23
pubmed: 24146121
Int J Hypertens. 2011;2011:391762
pubmed: 21629870
J Am Coll Nutr. 2006 Jun;25(3 Suppl):247S-255S
pubmed: 16772636
Free Radic Biol Med. 2005 Jan 15;38(2):286-93
pubmed: 15607912
J Am Heart Assoc. 2016 Oct 14;5(10):
pubmed: 27742615
Circ Res. 2021 Apr 2;128(7):1021-1039
pubmed: 33793338
J Clin Endocrinol Metab. 2004 Mar;89(3):1140-5
pubmed: 15001599
Nutrients. 2019 Aug 21;11(9):
pubmed: 31438636
Diabetes. 2018 Nov;67(11):2361-2376
pubmed: 30181158
Hypertension. 1983 Nov-Dec;5(6):814-20
pubmed: 6654449
Hypertension. 2017 Sep;70(3):559-565
pubmed: 28674038
Biochem Biophys Res Commun. 1994 Jul 29;202(2):688-93
pubmed: 8048938
Hypertension. 1991 Dec;18(6):805-12
pubmed: 1743761
Hypertension. 1986 Jun;8(6 Pt 2):II127-34
pubmed: 3522418
J Clin Hypertens (Greenwich). 2013 Jul;15(7):485-96
pubmed: 23815537
PLoS One. 2018 Oct 3;13(10):e0203823
pubmed: 30281670
Nat Commun. 2020 Aug 24;11(1):4222
pubmed: 32839436
Diabetologia. 2010 Aug;53(8):1568-75
pubmed: 20414637
Am J Physiol Renal Physiol. 2002 Sep;283(3):F532-9
pubmed: 12167605
Hypertension. 2000 Jan;35(1 Pt 2):512-7
pubmed: 10642351
Lancet. 2005 Oct 8;366(9493):1279-89
pubmed: 16214598
Diabetes. 2006 Dec;55(12):3594-603
pubmed: 17130509
Cell Rep. 2017 Oct 24;21(4):1009-1020
pubmed: 29069584
Cell. 2015 Jul 30;162(3):465-6
pubmed: 26232214
Mol Cell Biochem. 2007 Dec;306(1-2):133-9
pubmed: 17660951
Hypertension. 2007 May;49(5):1032-9
pubmed: 17372035
Am J Physiol Regul Integr Comp Physiol. 2010 Apr;298(4):R1089-97
pubmed: 20147609
J Biol Chem. 2007 Sep 21;282(38):28175-88
pubmed: 17635925
Am J Physiol. 1995 Aug;269(2 Pt 1):C295-311
pubmed: 7653511
Nephrol Dial Transplant. 2020 Dec 22;:
pubmed: 33351140
Curr Mol Pharmacol. 2012 Jun;5(2):292-300
pubmed: 22122459
Nat Med. 2009 Aug;15(8):914-20
pubmed: 19633658
J Hypertens. 1999 Sep;17(9):1229-37
pubmed: 10489099
Arterioscler Thromb Vasc Biol. 2000 Jan;20(1):10-7
pubmed: 10634795
Metabolism. 1993 Aug;42(8):1027-30
pubmed: 8345807
Nat Neurosci. 2018 Feb;21(2):240-249
pubmed: 29335605
Cell. 1998 Apr 17;93(2):241-52
pubmed: 9568716
Kidney Int. 2015 Mar;87(3):535-42
pubmed: 25354240
J Clin Invest. 2003 Dec;112(12):1821-30
pubmed: 14679177
Sci Rep. 2017 May 10;7(1):1698
pubmed: 28490763
Clin Sci (Lond). 2015 Dec;129(12):1025-36
pubmed: 26265791
Hypertension. 2001 Feb;37(2 Pt 2):429-32
pubmed: 11230313
Clin Sci (Lond). 1996 Aug;91(2):155-61
pubmed: 8795438
Mol Cell Biochem. 2003 Jan;242(1-2):57-63
pubmed: 12619866
Diabetes. 2004 Jun;53(6):1418-23
pubmed: 15161743
FASEB J. 2013 Jul;27(7):2723-32
pubmed: 23558339
FEBS J. 2013 Jul;280(14):3232-43
pubmed: 23617393
Am J Respir Cell Mol Biol. 2017 Jan;56(1):131-144
pubmed: 27612006
Pflugers Arch. 2009 May;458(1):111-35
pubmed: 19277701
Life Sci. 2012 Oct 15;91(13-14):600-6
pubmed: 22521290
Am J Physiol Heart Circ Physiol. 2004 Jul;287(1):H203-8
pubmed: 14975935
Mol Cells. 2012 Jun;33(6):591-6
pubmed: 22544171
J Hypertens. 2009 Aug;27(8):1664-71
pubmed: 19531965
Cardiovasc Res. 2021 Jan 1;117(1):308-319
pubmed: 32428209
Am J Physiol Endocrinol Metab. 2004 Nov;287(5):E948-54
pubmed: 15226099
Biochem Biophys Res Commun. 1999 Jan 27;254(3):757-63
pubmed: 9920814
Diabetes Res Clin Pract. 2007 May;76(2):236-44
pubmed: 17097186
J Clin Invest. 2014 Oct;124(10):4642-56
pubmed: 25244096
Cell. 2014 Dec 4;159(6):1404-16
pubmed: 25480301
Int J Cardiol. 2013 Sep 10;167(6):2605-10
pubmed: 22809536
J Pharmacol Exp Ther. 2018 May;365(2):212-218
pubmed: 29467310
Transl Res. 2018 Dec;202:52-68
pubmed: 30165038
Annu Rev Physiol. 2010;72:219-46
pubmed: 20148674
Eur Heart J. 2021 May 7;42(18):1742-1756
pubmed: 33748830
J Atheroscler Thromb. 2014;21(6):563-73
pubmed: 24477028
J Hypertens. 2008 Apr;26(4):765-72
pubmed: 18327087
Nat Med. 2011 Feb;17(2):179-88
pubmed: 21217695
Circ Res. 2015 Mar 13;116(6):1022-33
pubmed: 25767287
Vascul Pharmacol. 2017 Jan;88:30-41
pubmed: 27890480
Hypertension. 2008 Sep;52(3):452-9
pubmed: 18678788
Clin Chim Acta. 2005 May;355(1-2):131-6
pubmed: 15820487
N Engl J Med. 1994 Nov 3;331(18):1188-93
pubmed: 7935656
Circulation. 2017 May 30;135(22):2155-2162
pubmed: 28330983
Acta Physiol (Oxf). 2018 Mar;222(3):
pubmed: 29193764
Oxid Med Cell Longev. 2019 Dec 6;2019:3940739
pubmed: 31885787
Trends Immunol. 2002 Nov;23(11):549-55
pubmed: 12401408
Nature. 2012 Jun 28;486(7404):549-53
pubmed: 22722857
Nature. 2010 Apr 29;464(7293):1357-61
pubmed: 20428172
Am J Physiol Renal Physiol. 2019 Oct 1;317(4):F1058-F1067
pubmed: 31411073
Proc Natl Acad Sci U S A. 2018 Mar 20;115(12):3138-3143
pubmed: 29507217
Science. 1991 Jun 28;252(5014):1813-6
pubmed: 2063193
Hypertension. 2017 Jul;70(1):174-182
pubmed: 28507170
Front Endocrinol (Lausanne). 2020 Feb 19;11:62
pubmed: 32140136
J Transl Med. 2021 Jan 20;19(1):38
pubmed: 33472641
J Immunol. 2010 Aug 1;185(3):1836-45
pubmed: 20581149
J Endocrinol. 2018 Aug;238(2):R79-R94
pubmed: 29848608
Hypertension. 1999 Jul;34(1):113-7
pubmed: 10406833
Mediators Inflamm. 2010;2010:568343
pubmed: 20368778
J Cardiovasc Pharmacol. 2006 Mar;47(3):385-90
pubmed: 16633080
Hypertension. 1989 Jun;13(6 Pt 1):612-21
pubmed: 2525523
Am J Physiol Endocrinol Metab. 2020 Sep 1;319(3):E629-E646
pubmed: 32776829
Kidney Int. 2015 Mar;87(3):497-9
pubmed: 25723632
FASEB J. 2015 Dec;29(12):4937-44
pubmed: 26268928
J Hum Hypertens. 2001 Jul;15(7):481-5
pubmed: 11464258
Pharmacology. 2014;94(5-6):259-64
pubmed: 25471554
Lancet. 1997 Dec 13;350(9093):1734-7
pubmed: 9413464
Diabetes. 1999 Jul;48(7):1448-53
pubmed: 10389852
J Obes. 2013;2013:616193
pubmed: 23577240
Hypertension. 1979 Jan-Feb;1(1):3-7
pubmed: 544511
Nat Rev Immunol. 2010 Dec;10(12):826-37
pubmed: 21088683
Hypertension. 1996 Apr;27(4):919-25
pubmed: 8613269
FASEB J. 2006 Jul;20(9):1555-7
pubmed: 16723378
Hypertension. 1980 May-Jun;2(3):274-80
pubmed: 7390606
J Hypertens. 1991 Apr;9(4):329-35
pubmed: 1646259
Diabetologia. 2003 Jan;46(1):124-31
pubmed: 12637991
Hum Vaccin Immunother. 2014;10(11):3270-85
pubmed: 25625930
Exp Biol Med (Maywood). 2006 Jun;231(6):813-7
pubmed: 16741004
Steroids. 2010 Nov;75(11):794-9
pubmed: 19883672
Nutrients. 2019 Nov 08;11(11):
pubmed: 31717265
J Clin Hypertens (Greenwich). 2006 Jan;8(1):19-28
pubmed: 16407685
Biosci Rep. 2019 Feb 27;39(2):
pubmed: 30777927
Nature. 2007 Jun 28;447(7148):1116-20
pubmed: 17515919
Diabetes. 2006 May;55(5):1289-99
pubmed: 16644685
Am J Hypertens. 1995 Aug;8(8):855-8
pubmed: 7576404
J Hum Hypertens. 1997 Dec;11(12):795-800
pubmed: 9468006
Diabetes. 2003 Jul;52(7):1655-63
pubmed: 12829629
Nat Med. 2009 May;15(5):545-52
pubmed: 19412173
Am J Clin Nutr. 2010 Jul;92(1):77-82
pubmed: 20444953
Am J Physiol Heart Circ Physiol. 2009 Mar;296(3):H833-9
pubmed: 19151253
Hypertension. 2017 Apr;69(4):660-668
pubmed: 28167686
Nat Immunol. 2021 Sep;22(9):1175-1185
pubmed: 34429546
Eur J Clin Invest. 2003 Feb;33(2):141-6
pubmed: 12588288
Cell. 2014 May 22;157(5):1013-22
pubmed: 24855941
Int J Mol Sci. 2019 Aug 09;20(16):
pubmed: 31395800
Hypertension. 2013 Mar;61(3):635-40
pubmed: 23339169
J Biol Chem. 2009 Mar 6;284(10):6116-25
pubmed: 19126543
Cell Metab. 2012 Oct 3;16(4):462-72
pubmed: 23040068
Endocrinology. 2007 Apr;148(4):1835-42
pubmed: 17194742
Circ Res. 2012 Nov 9;111(11):1446-58
pubmed: 22962432
Diabetologia. 1998 Apr;41(4):369-79
pubmed: 9562340
Nature. 1999 Dec 23-30;402(6764):880-3
pubmed: 10622252
Immunol Cell Biol. 2012 Sep;90(8):755-62
pubmed: 22231651
Int J Mol Sci. 2021 Jan 21;22(3):
pubmed: 33494430
Hypertension. 1998 Nov;32(5):862-8
pubmed: 9822445
Endocrinology. 2010 May;151(5):1998-2007
pubmed: 20228173
Front Pharmacol. 2018 Aug 22;9:968
pubmed: 30186184
Nat Med. 2013 May;19(5):557-66
pubmed: 23652116
J Clin Invest. 2013 Jul;123(7):2803-15
pubmed: 23722907
Free Radic Biol Med. 2014 Feb;67:211-20
pubmed: 24140862
Diabetes. 2009 Dec;58(12):2731-40
pubmed: 19720798
Curr Hypertens Rep. 2010 Aug;12(4):243-51
pubmed: 20582734
Diabetol Metab Syndr. 2014 Jan 31;6(1):12
pubmed: 24485020
Diabetes Care. 2003 Jan;26(1):172-8
pubmed: 12502676
Cell. 1988 Jul 15;54(2):263-73
pubmed: 2455603
Am J Physiol. 1999 Nov;277(5):R1392-400
pubmed: 10564212
J Hypertens. 2010 Mar;28(3):527-35
pubmed: 19898250
Hypertension. 2014 Nov;64(5):1108-15
pubmed: 25259750
Clin Cardiol. 2008 Sep;31(9):397-403
pubmed: 18781598
Arterioscler Thromb Vasc Biol. 2012 Feb;32(2):257-63
pubmed: 22173225
Physiol Genomics. 2019 Nov 1;51(11):553-561
pubmed: 31588871
FEBS Lett. 2008 Mar 5;582(5):573-8
pubmed: 18242188
Am J Physiol Heart Circ Physiol. 2016 Jan 1;310(1):H39-48
pubmed: 26566726
Obesity (Silver Spring). 2017 Feb;25(2):468-475
pubmed: 28071854
Nat Clin Pract Cardiovasc Med. 2009 Mar;6(3):192-9
pubmed: 19234499
Endocr Connect. 2020 May;9(5):360-369
pubmed: 32244224
Circ Res. 2006 Jul 21;99(2):140-8
pubmed: 16778129
Cardiovasc Diabetol. 2008 Apr 24;7:10
pubmed: 18435852
Gen Thorac Cardiovasc Surg. 2015 Oct;63(10):565-71
pubmed: 26213347
Hypertension. 2016 Jul;68(1):195-203
pubmed: 27160204
Trends Endocrinol Metab. 2012 Jul;23(7):351-63
pubmed: 22704720
J Clin Invest. 1989 Nov;84(5):1620-8
pubmed: 2681272
J Clin Invest. 2000 Jan;105(2):199-205
pubmed: 10642598
J Clin Invest. 2013 Mar;123(3):1003-4
pubmed: 23454764

Auteurs

Lale A Ertuglu (LA)

Division of Nephrology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, United States.

Fernando Elijovich (F)

Division of Clinical Pharmacology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, United States.

Cheryl L Laffer (CL)

Division of Clinical Pharmacology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, United States.

Annet Kirabo (A)

Division of Clinical Pharmacology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, United States.

Classifications MeSH